BDNF genetic variations increase the risk of Alzheimer's disease-related depression.

The gene encoding the brain-derived neurotrophic factor (BDNF) has been demonstrated as a candidate for Alzheimer's disease-related depression (AD-D) susceptibility. Additionally, an association between AD-D and the functional valine to methionine (Val66Met) polymorphism has been reported. The aim of this study was to assess the genetic contribution of other BDNF variants to AD-D. Two-hundred forty-five AD patients were divided into two subgroups according to the presence (AD-D) or the absence (AD-nD) of depressive symptoms. Four single-nucleotide polymorphisms within BDNF gene were considered, i.e., C270T, rs2049045 C/G, G196A (Val66Met), and G11757C. In our sample, 35.5% of patients (n = 87) reported AD-related depressive symptoms. The individual SNP analysis showed an association between G196A and G11757C genotypes and AD-D. Accordingly, considering the allele frequencies, BDNF 196*A allele was significantly overrepresented in AD-D compared to AD-nD (OR = 1.80, 95% CI = 1.19-2.72), as well as BDNF 11757*C allele (OR = 1.90, 95% CI = 1.25-2.90). Haplotype analyses revealed that the alleles at four loci (C270T, rs2049045 C/G, G196A, G11757C) interacted to further increase the risk of AD-D. Compared to the most common not-at-risk C-C-G-G haplotype, C-G-A-C (OR = 3.55, 95% CI = 1.44-8.76, P = 0.006) and C-C-A-C haplotypes (OR = 1.72, 95% CI = 1.03-2.87, P = 0.037) were overrepresented in AD-D. This study suggests that BDNF genetic variations play a role in the susceptibility to AD-related depression.

[1]  C. Caltagirone,et al.  Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression , 2009, Neurobiology of Aging.

[2]  R. Duman,et al.  Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications , 2008, Biological Psychiatry.

[3]  R. Stewart,et al.  BDNF genotype potentially modifying the association between incident stroke and depression , 2008, Neurobiology of Aging.

[4]  Stephan Züchner,et al.  Allelic differences in the brain-derived neurotrophic factor Val66Met polymorphism in late-life depression. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[5]  H. Manji,et al.  New insights into BDNF function in depression and anxiety , 2007, Nature Neuroscience.

[6]  Tadafumi Kato,et al.  Molecular genetics of bipolar disorder and depression , 2007, Psychiatry and clinical neurosciences.

[7]  Serge Nef,et al.  Brain-Derived Neurotrophic Factor Conditional Knockouts Show Gender Differences in Depression-Related Behaviors , 2007, Biological Psychiatry.

[8]  Jiing-Feng Lirng,et al.  The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression , 2006, Neurobiology of Aging.

[9]  Se-Won Lim,et al.  Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder , 2006, Brain Research.

[10]  S. Cichon,et al.  Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: An association study , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[11]  S. Cichon,et al.  Evidence for a Relationship Between Genetic Variants at the Brain-Derived Neurotrophic Factor (BDNF) Locus and Major Depression , 2005, Biological Psychiatry.

[12]  N. Gervasoni,et al.  Partial Normalization of Serum Brain-Derived Neurotrophic Factor in Remitted Patients after a Major Depressive Episode , 2005, Neuropsychobiology.

[13]  Russo-Neustadt Aa,et al.  Brain-derived neurotrophic factor and antidepressant activity. , 2005, Current pharmaceutical design.

[14]  F. Taneli,et al.  Effect of treatment on serum brain–derived neurotrophic factor levels in depressed patients , 2005, European Archives of Psychiatry and Clinical Neuroscience.

[15]  Sönke Arlt,et al.  Detecting depression in Alzheimer's disease: evaluation of four different scales. , 2005, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[16]  Lue Ping Zhao,et al.  Estimating haplotype frequencies and standard errors for multiple single nucleotide polymorphisms. , 2003, Biostatistics.

[17]  Constantine G Lyketsos,et al.  Depression in Alzheimer’s disease: heterogeneity and related issues , 2003, Biological Psychiatry.

[18]  Lue Ping Zhao,et al.  A method for the assessment of disease associations with single-nucleotide polymorphism haplotypes and environmental variables in case-control studies. , 2003, American journal of human genetics.

[19]  M. Egan,et al.  The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function , 2003, Cell.

[20]  R. Duman,et al.  Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression , 2002, The Journal of Neuroscience.

[21]  R. Duman.  Synaptic plasticity and mood disorders , 2002, Molecular Psychiatry.

[22]  G. MacQueen,et al.  Increased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication , 2001, Biological Psychiatry.

[23]  N. Seidah,et al.  Biosynthesis and Post-translational Processing of the Precursor to Brain-derived Neurotrophic Factor* , 2001, The Journal of Biological Chemistry.

[24]  M. Mega,et al.  The Neuropsychiatric Inventory , 1994, Neurology.

[25]  A. Saunders,et al.  Dinucleotide repeat polymorphism at the human gene for the brain-derived neurotrophic factor (BDNF). , 1992, Human molecular genetics.

[26]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[27]  M. Zatz,et al.  Lack of association between the brain-derived neurotrophin factor (C-270T) polymorphism and late-onset Alzheimer’s disease (LOAD) in Brazilian patients , 2007, Journal of Molecular Neuroscience.

[28]  Hans Förstl,et al.  A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E ε4 allele , 2002, Molecular Psychiatry.

[29]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.